MONOCLONAL-ANTIBODY TECHNIQUE FOR DETECTION OF ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER - GREATER SENSITIVITY AND MORE ACCURATE CLASSIFICATION OF RECEPTOR STATUS THAN THE DEXTRAN-COATED CHARCOAL METHOD
- 15 December 1987
- journal article
- research article
- Vol. 47 (24) , 6572-6575
Abstract
Estrogen receptor (ER) concentrations have been determined in 191 freshly prepared cytosols from breast cancer biopsies using both the monoclonal enzyme immunoassay (ER-EIA) and the dextran-coated charcoal (ER-DCC) methods in a single laboratory. The concentrations of the ER detected using the two methods are highly and significantly correlated (linear regression curve: ER-EIA = 15.5 .female. 0.82 ER-DCC; r = 0.97). Nevertheless, it may be most correct to interpret the data by resolving the correlation into two lines, one describing the fit for cytosols with low and intermediate concentrations (the first 75% of the distribution of ER values for all primary breast cancers: < 217 fmol ER/mg cytosol protein) and one describing the fit for cytosols with the highest ER concentrations (i.e., .gtoreq. 217 fmol ER/mg cytosol protein). Using a cutoff limit of 10 fmol/mg cytosol protein to distinguish between ER positive and ER negative biopsies, discrepancies in the classification of ER status were found in only 6% (12 of 191) of the cases using the two different methods. In all 12 cases, the ER concentrations as determined by both methods were in the lower range of receptor concentrations (0-53 fmol/mg cytosol protein). Of the 12 discrepancies, 10 biopsies were classified as ER negative using the ER-DCC method but ER positive using the ER-EIA method. Additional available data for these 10 patients indicate that the ER-EIA assay yielded the more biologically "correct" result. All 10 of these biopsies were either progesterone receptor positive or had nuclear ER. By identifying the outliers of the linear regression curves (points exceeding the 80% confidence interval) of the logarithmically transformed ER concentrations, 9 of the 12 biopsies were identified. Thus, it is unlikely that the observed discrepancies are due to random events in most cases here. Since most of the few deviations observed appear to represent true differences in the sensitivities of the two methods, the ER-EIA method appears to be superior to the ER-DCC method in our hands. The concentration of ER in 47 cytosols stored at =70.degree. C for 3-6 yr was analyzed using the ER-EIA method, and results were compared to the concentration of ER found using the ER-DCC method on freshly prepared cytosols when the biopsies had been received at the laboratory. The linear regression curve of the correlation between ER concentrations determined using the two methods did not differ significantly from that found for the 191 freshly prepared cytosols.This publication has 12 references indexed in Scilit:
- Standardization of steroid receptor assays in human breast cancer—IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assaysEuropean Journal of Cancer and Clinical Oncology, 1986
- Standardization of steroid receptor assays in human breast cancer—III. Selection of reference material for intra- and inter-laboratory quality controlEuropean Journal of Cancer and Clinical Oncology, 1986
- The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysisEuropean Journal of Cancer and Clinical Oncology, 1986
- Prognostic implication of estrogen receptor content in breast cancerBreast Cancer Research and Treatment, 1985
- The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breastBritish Journal of Cancer, 1985
- Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosolsClinical Biochemistry, 1985
- Standardization of steroid receptor assays in human breast cancer—II. Samples with low receptor contentEuropean Journal of Cancer and Clinical Oncology, 1983
- Standardization of steroid receptor assays in human breast cancer—I. Reproducibility of estradiol and progesterone receptor assaysEuropean Journal of Cancer and Clinical Oncology, 1983
- PROGESTERONE AND ESTROGEN-RECEPTORS AS PROGNOSTIC VARIABLES IN BREAST-CANCER1983
- A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assaysEuropean Journal of Cancer and Clinical Oncology, 1982